Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2012
12/06/2012WO2012164085A1 Glycine b antagonists
12/06/2012WO2012164071A1 Imidazole derivatives
12/06/2012WO2012163792A1 Novel p2x7r antagonists and their use
12/06/2012WO2012163456A1 Novel p2x7r antagonists and their use
12/06/2012US20120309985 3-phenoxymethylpyrrolidine compounds
12/06/2012US20120309977 Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
12/06/2012US20120309972 Tetrazolyloxime derivative or salt thereof and fungicide
12/06/2012US20120309964 Cyclic amine compound and acaricide
12/06/2012US20120309770 Compounds for the Treatment of Hepatitis C
12/06/2012US20120309769 N-benzylindole modulators of pparg
12/06/2012US20120309757 N-biphenylmethylindole modulators of pparg
12/06/2012US20120309751 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
12/06/2012US20120309739 Akt / pkb inhibitors
12/06/2012US20120309738 Novel compounds
12/06/2012US20120309736 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
12/06/2012US20120309702 Dynamic inhibitors of heat shock protein 90
12/06/2012US20120308587 Neprilysin inhibitors
12/06/2012US20120305900 Compound for organic photoelectric device and organic photoelectric device including the same
12/06/2012CA2837517A1 Imidazole derivatives
12/06/2012CA2835216A1 Neprilysin inhibitors
12/05/2012EP2530075A2 Modulators of ATP-binding cassette transporters
12/05/2012EP2528914A1 Furo [3, 2 -b]pyrane derivatives useful in the synthesis of halichondrin b analogs
12/05/2012EP2528910A1 5-alkynyl pyrimidines and their use as kinase inhibitors
12/05/2012EP2528903A1 5-alkynyl-pyrimidines
12/05/2012EP2528902A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/05/2012EP2528897A1 Di - substituted pyridine derivatives as anticancers
12/05/2012EP2528896A1 Synthetic intermediate of oxazole compound and method for producing the same
12/05/2012EP2528890A1 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators
12/05/2012EP2528606A1 Quinazoline-based t cell proliferation inhibitors
12/05/2012CN102812020A Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
12/05/2012CN102812019A Process and intermediates for preparing lapatinib
12/05/2012CN102812014A Novel Oxime Derivatives And Their Use As Allosteric Modulators Of Metabotropic Glutamate Receptors
12/05/2012CN102812013A Novel Kinase Modulators
12/05/2012CN102812006A New anti-malarial agents
12/05/2012CN102812004A Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using the same
12/05/2012CN102812003A Pyrrolidine Or Thiazolidine Carboxylic Acid Derivatives, Pharmaceutical Composition And Methods For Use In Treating Metabolic Disordersas As Agonists Of G- Protein Coupled Receptor 43 (GPR43)
12/05/2012CN102807551A Novel liquid crystal compound containing dioxa saturated azulenes and composition thereof
12/05/2012CN102807531A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
12/05/2012CN102115471B Triazole compound as well as preparation method and application thereof
12/05/2012CN102086193B N-substituted alpha-amino acid derivatives and preparation method and application thereof
12/05/2012CN102060850B Preparing and refining methods of difenoconazole
12/05/2012CN101535258B Ether derivatives dual modulators of the 5-ht2a and d3 receptors
12/05/2012CN101255131B Heterocyclic derivatives as opioid modulators
12/04/2012US8324391 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors
12/04/2012US8324385 Diacylglycerol acyltransferase inhibitors
12/04/2012US8324284 Migrastatin analogs and uses thereof
12/04/2012US8324253 Crystalline modification of 4-(N-methyl-Z-chloro-5pyridy methylamino)-2, 5-dihydrofuran-2-on
12/04/2012US8324245 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/04/2012US8324220 Pyrimidines useful as modulators of voltage-gated ion channels
12/04/2012US8324213 Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators
12/04/2012US8324203 Azadecalin glucocorticoid receptor modulators
12/04/2012US8324133 Fungicide 2-pyridyl-methylene-carboxamide derivatives
12/04/2012CA2557269C Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
12/04/2012CA2520732C Migrastatin analogs and uses thereof
12/04/2012CA2518932C 2,4-di(phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/2012
11/29/2012WO2012162254A1 Inhibitors of lrrk2 kinase activity
11/29/2012WO2012160447A1 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
11/29/2012WO2012160034A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/29/2012WO2012159557A1 Substituted triazine phenylurea derivative and use thereof against tumors
11/29/2012WO2012136873A3 Triazine derivatives and their uses as trpv1 inhibitors
11/29/2012US20120302757 Synthetic intermediate of oxazole compound and method for producing the same
11/29/2012US20120302748 Treatment or prophylaxis of proliferative conditions
11/29/2012US20120302746 3-pyridylcarbonyl-piperazinylsulfonyl derivatives
11/29/2012US20120302745 Exo-selective synthesis of himbacine analogs
11/29/2012US20120302617 Phenyl and Benzodioxinyl Substituted Indazoles Derivatives
11/29/2012US20120302609 Pyrazolines for the Modulation of PKM2
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302566 Indanyloxydihydrobenzofuranylacetic acids
11/29/2012US20120302563 Substituted norindenoisoquinolines, syntheses thereof, and methods of use
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302531 beta-2-Adrenoreceptor Agonists
11/29/2012US20120299473 Aminoanthracene derivative and organic electroluminescent element formed using same
11/29/2012CA2837199A1 Inhibitors of lrrk2 kinase activity
11/29/2012CA2837027A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/28/2012EP2527342A2 Derivatives of UK-2A
11/28/2012EP2527339A1 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
11/28/2012EP2527337A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
11/28/2012EP2527334A1 Aromatic amine derivative, and organic electroluminescent element comprising same
11/28/2012EP2527326A1 Novel compounds having 4-pyridylalkylthio group as substituent
11/28/2012EP2526099A2 Improved process for the preparation of amide intermediates and their use thereof
11/28/2012EP2526092A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
11/28/2012EP2526090A2 New anti-malarial agents
11/28/2012CN102803254A Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs
11/28/2012CN102803253A 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
11/28/2012CN102803252A Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
11/28/2012CN102803249A Hepatitis c virus inhibitors
11/28/2012CN102803234A Antagonism of human formyl peptide receptor for treatment of disease
11/28/2012CN102803228A Acid-labile trigger units
11/28/2012CN102803223A Cyclic compound having substituted phenyl group
11/28/2012CN102803210A Azetidinyl diamides as monoacylglycerol lipase inhibitors
11/28/2012CN102802416A Fungicidal mixtures
11/28/2012CN102796110A Aniline pyrimidine compound and preparation method and application thereof
11/28/2012CN102796109A 4-aminoquinazoline compound and preparation method and application thereof
11/28/2012CN102796087A Coumarin triadimenol, and preparation method and application thereof
11/28/2012CN102796086A Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
11/28/2012CN102796085A Coumarin triazole, and preparation method and application thereof
11/28/2012CN102796081A Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/28/2012CN102796075A Benzocycloheptenes derivative as well as preparation method and medical application thereof
11/28/2012CN101899039B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 694